Home

tumbă Ofiţer dinamică nste-acs dapt duration segment rechemare Lin

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet  Therapy in Patients With Coronary Artery Disease: A Report of the American  College of Cardiology/American Heart Association Task Force on Clinical  Practice
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice

Questions Remain on DAPT Prolongation | DAIC
Questions Remain on DAPT Prolongation | DAIC

Selection of non-ST-elevation acute coronary syndrome (NSTE-ACS)... |  Download Scientific Diagram
Selection of non-ST-elevation acute coronary syndrome (NSTE-ACS)... | Download Scientific Diagram

ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline  Comparison - ScienceDirect
ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline Comparison - ScienceDirect

Dual antiplatelet therapy for secondary prevention of coronary artery  disease | Open Heart
Dual antiplatelet therapy for secondary prevention of coronary artery disease | Open Heart

ACCF/AHA 2014 NSTE-ACS antiplatelet therapy by treatment strategy. |  Download High-Resolution Scientific Diagram
ACCF/AHA 2014 NSTE-ACS antiplatelet therapy by treatment strategy. | Download High-Resolution Scientific Diagram

Dapt Review
Dapt Review

1 Duration of DAPT in patients who undergo PCI
1 Duration of DAPT in patients who undergo PCI

Antithrombotic strategies in elderly patients with acute coronary syndrome  - ScienceDirect
Antithrombotic strategies in elderly patients with acute coronary syndrome - ScienceDirect

Algorithm for DAPT in patients with coronary artery disease. ACS =... |  Download Scientific Diagram
Algorithm for DAPT in patients with coronary artery disease. ACS =... | Download Scientific Diagram

Antiplatelet therapy after percutaneous coronary intervention -  EuroIntervention
Antiplatelet therapy after percutaneous coronary intervention - EuroIntervention

Early anticoagulation in the current management of NSTE-ACS: Evidence,  guidelines, practice and perspectives - International Journal of Cardiology
Early anticoagulation in the current management of NSTE-ACS: Evidence, guidelines, practice and perspectives - International Journal of Cardiology

Antiplatelet therapy in acute coronary syndrome - Brown - 2017 - Continuing  Cardiology Education - Wiley Online Library
Antiplatelet therapy in acute coronary syndrome - Brown - 2017 - Continuing Cardiology Education - Wiley Online Library

JCM | Free Full-Text | Diagnosis and Management of Acute Coronary Syndrome:  What is New and Why? Insight From the 2020 European Society of Cardiology  Guidelines | HTML
JCM | Free Full-Text | Diagnosis and Management of Acute Coronary Syndrome: What is New and Why? Insight From the 2020 European Society of Cardiology Guidelines | HTML

Dual antiplatelet therapy for secondary prevention of coronary artery  disease | Open Heart
Dual antiplatelet therapy for secondary prevention of coronary artery disease | Open Heart

European Society of Cardiology - How would you select long-term dual  antiplatelet therapy? How do you implement currently available tools for  ischemic and bleeding risk stratification? That and much more for you
European Society of Cardiology - How would you select long-term dual antiplatelet therapy? How do you implement currently available tools for ischemic and bleeding risk stratification? That and much more for you

2020 ESC Guidelines on acute coronary syndrome without ST-segment elevation  | SpringerLink
2020 ESC Guidelines on acute coronary syndrome without ST-segment elevation | SpringerLink

Duration of Dual Anti-Platelet Therapy After Percutaneous Coronary  Intervention With Drug-Eluting Stents | SCAI
Duration of Dual Anti-Platelet Therapy After Percutaneous Coronary Intervention With Drug-Eluting Stents | SCAI

Optimal duration of dual antiplatelet therapy post percutaneous coronary  intervention in acute coronary syndrome - ScienceDirect
Optimal duration of dual antiplatelet therapy post percutaneous coronary intervention in acute coronary syndrome - ScienceDirect

NSTEMI: Myocardial Revascularization » ACVP Online
NSTEMI: Myocardial Revascularization » ACVP Online

2018 Canadian Cardiovascular Society/Canadian Association of Interventional  Cardiology Focused Update of the Guidelines for the Use of Antiplatelet  Therapy - Canadian Journal of Cardiology
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy - Canadian Journal of Cardiology

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet  Therapy in Patients With Coronary Artery Disease: A Report of the American  College of Cardiology/American Heart Association Task Force on Clinical  Practice
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice

Recent changes in recommendations of prolonged dual antiplatelet... |  Download Scientific Diagram
Recent changes in recommendations of prolonged dual antiplatelet... | Download Scientific Diagram

2016 Duration of DAPT Focused Update-gh jh
2016 Duration of DAPT Focused Update-gh jh

Fernando de la Guía 🩺 on Twitter: "Atrial fibrillation patients undergoing  PCI for NSTE-ACS. Triple therapy (N)OAC + DAPT up to 1 week (in hospital)  and after... 🧐 and finally (N)OAC alone! #
Fernando de la Guía 🩺 on Twitter: "Atrial fibrillation patients undergoing PCI for NSTE-ACS. Triple therapy (N)OAC + DAPT up to 1 week (in hospital) and after... 🧐 and finally (N)OAC alone! #

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet  Therapy in Patients With Coronary Artery Disease: A Repor
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Repor

Dual antiplatelet therapy for secondary prevention of coronary artery  disease | Open Heart
Dual antiplatelet therapy for secondary prevention of coronary artery disease | Open Heart